The role of Imeglimin in glycemic control, beta cell function and safety outcomes in patients with type 2 diabetes mellitus: A comprehensive meta-analysis
Purpose: The aim of this meta-analysis is to evaluate the role of Imeglimin in glycemic control (HbA1c & FPG), Homeostatic Model Assessment of β-cell function, pro-insulin to c-peptide ratio and its safety outcomes in patients with type 2 diabetes mellitus. Methods: A thorough literature sea...
Main Authors: | Palaniappan Vinayagam, Vengojayparassad Senathipathi, Vishnu Shivam, Nandhini Velraju |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Diabetes Epidemiology and Management |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666970623000367 |
Similar Items
-
Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta‐analysis of randomized controlled trials
by: Katsuhiko Hagi, et al.
Published: (2023-11-01) -
Comparative evaluation of clinical glycemic control markers treated with imeglimin and its effect on erythrocytes in patients with type 2 diabetes mellitus: study protocol of a single-arm, open-label, prospective, exploratory trial
by: Takeshi Osonoi, et al.
Published: (2023-06-01) -
Imeglimin‐mediated glycemic control in maternally inherited deafness and diabetes
by: Ryoichi Ishibashi, et al.
Published: (2023-12-01) -
Development of Imeglimin Electrospun Nanofibers as a Potential Buccal Antidiabetic Therapeutic Approach
by: Ali A. Alamer, et al.
Published: (2023-04-01) -
Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ
by: Junpei Sanada, et al.
Published: (2024-03-01)